Johan Törlén

Effect of Total Nucleated and CD34+ Cell Dose on Outcome after Allogeneic Hematopoietic Stem Cell Transplantation

Mats Remberger, Johan Törlén, Olle Ringdén et al. · Biology of Blood and Marrow Transplantation · 2015 · 126 citations · Full text

A prospective randomized trial comparing cyclosporine/methotrexate and tacrolimus/sirolimus as graft-versus-host disease prophylaxis after allogeneic hematopoietic stem cell transplantation

Johan Törlén, Olle Ringdén, Karin Garming-Legert et al. · Haematologica · 2016 · 70 citations · Full text

Low CD34 Dose Is Associated with Poor Survival after Reduced-Intensity Conditioning Allogeneic Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndrome

Johan Törlén, Olle Ringdén, Jennifer Le Rademacher et al. · Biology of Blood and Marrow Transplantation · 2014 · 46 citations · Full text

Hematological Malignancy, Unrelated Donors, Transplantation +13

Combining Flow and Mass Cytometry in the Search for Biomarkers in Chronic Graft-versus-Host Disease

Arwen Stikvoort, Yang Chen, Emelie Rådestad et al. · Frontiers in Immunology · 2017 · 32 citations · Full text

Cgvhd Severity, Cell Therapy, Immunology +19

Effect of Graft-versus-Host Disease Prophylaxis Regimens on T and B Cell Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation

Johan Törlén, Ahmed Gaballa, Mats Remberger et al. · Biology of Blood and Marrow Transplantation · 2019 · 24 citations · Full text